The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
<p>Telomerase is expressed in the majority (>85%) of tumours but not in differentiated normal tissue. This enzyme catalyses the elongation of telomeres – a process critical for continued cell proliferation. Telomerase is a potential novel target for molecularly-targeted radiotherapy (mR...
Autor principal: | Jackson, M |
---|---|
Outros Autores: | Vallis, K |
Formato: | Thesis |
Idioma: | English |
Publicado em: |
2013
|
Assuntos: |
Registos relacionados
-
Selective targeting of homologous recombination deficiency
Por: Zimmer, J
Publicado em: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
Por: Albukhari, A
Publicado em: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
Por: Albukhari, A
Publicado em: (2014) -
Development of models and methods to assess the efficacy of anti-cancer drugs targeted to the mitochondria
Por: Potter, M
Publicado em: (2014) -
Radiopharmaceutical Validation for Clinical Use
Por: Charles A. Kunos, et al.
Publicado em: (2021-03-01)